{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:34:19Z","timestamp":1767008059641},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.12.022","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T10:28:55Z","timestamp":1419071335000},"page":"635-641","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Determining rubella immunity in pregnant Alberta women 2009\u20132012"],"prefix":"10.1016","volume":"33","author":[{"given":"Florence Y.","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Dover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonita","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina S.","family":"Plitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Jaipaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham A.","family":"Tipples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen L.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.12.022_bib0005","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1503\/cmaj.050590","article-title":"A refresher on rubella","volume":"172","author":"Weir","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.13.4.571-587.2000","article-title":"Rubella virus replication and links to teratogenicity","volume":"13","author":"Lee","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1521-6942(03)00004-4","article-title":"Virus-associated arthritis","volume":"17","author":"Masuko-Hongo","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1179\/146532806X107511","article-title":"Blueberry muffin syndrome owing to congenital rubella: case report","volume":"26","author":"Koklu","year":"2006","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0025","series-title":"Elimination of measles, rubella and congenital rubella syndrome in Canada\u2014documentation and verification report","first-page":"1","author":"Public Health Agency of Canada","year":"2011"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/513967","article-title":"Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations","volume":"175","author":"Matter","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.12.022_bib0035","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1093\/clinids\/7.Supplement_1.S157","article-title":"Challenge with rubella virus after loss of detectable vaccine-induced antibody","volume":"7","author":"Schiff","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2105\/AJPH.56.7.1082","article-title":"The infectiousness of rubella and the possibility of reinfection","volume":"56","author":"Brody","year":"1966","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/JVI.57.3.893-898.1986","article-title":"Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies","volume":"57","author":"Green","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JCM.13.5.850-854.1981","article-title":"Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus","volume":"13","author":"Shekarchi","year":"1981","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.00688-12","article-title":"Performance of the Elecsys rubella IgG assay in the diagnostic laboratory setting for assessment of immune status","volume":"20","author":"Enders","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.vaccine.2014.12.022_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcv.2010.07.011","article-title":"Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards Rubella virus","volume":"49","author":"Portella","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0065","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00294-12","article-title":"Results of continuous monitoring of the performance of rubella virus IgG and hepatitis B virus surface antibody assays using trueness controls in a multicenter trial","volume":"19","author":"Kruk","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archpedi.1969.02100040157001","article-title":"Attenuated rubella viruses. Laboratory and clinical characteristics","volume":"118","author":"Meyer","year":"1969","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(94)90009-4","article-title":"Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults","volume":"12","author":"Christenson","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0080","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1155\/2009\/901372","article-title":"Rubella immunity among pregnant women in a Canadian provincial screening program","volume":"20","author":"Kearns","year":"2009","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2334-13-362","article-title":"Rubella immunity among prenatal women in Ontario, 2006\u20132010","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004\u20132009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0100","series-title":"Alberta prenatal screening program for selected communicable diseases. Public health guidelines","author":"Disease Control and Prevention Branch","year":"2006"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model extension and Akaike's information criteria (AIC): the general theory and its analytical extensions","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01316909","article-title":"Possibility of reinfection after immunisation with RA27\/3 live attenuated rubella virus","volume":"129","author":"Cusi","year":"1993","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3329\/dmcj.v2i2.20522","article-title":"Congenital rubella syndrome: an overview of clinical presentations in Bangladeshi children","volume":"2","author":"Nazme","year":"2014","journal-title":"Delta Med Coll J"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0130","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/j.vaccine.2012.09.075","article-title":"Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel","volume":"30","author":"Levine","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2012.11.043","article-title":"Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia","volume":"31","author":"Gao","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0140","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(97)00068-6","article-title":"Twenty years\u2019 experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination","volume":"15","author":"B\u00f6ttiger","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/oxfordjournals.aje.a113511","article-title":"Measles and rubella in the United States","volume":"117","author":"Hethcote","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.07.039","article-title":"Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005","volume":"25","author":"Muller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3476(82)80114-5","article-title":"Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized","volume":"101","author":"Robinson","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/148.4.639","article-title":"Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus","volume":"148","author":"O'Shea","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/infdis\/149.3.459","article-title":"Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests","volume":"149","author":"Storch","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0170","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jama.1984.03340390028023","article-title":"Serological response to rubella revaccination","volume":"251","author":"Serdula","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0175","series-title":"Detection and quantitation of rubella IgG antibody: evaluation and performance criteria for multiple component test products, specimen handling, and use of test products in the clinical laboratory; approved guideline","author":"National Committee on Clinical Laboratory Standards","year":"1997"},{"key":"10.1016\/j.vaccine.2014.12.022_bib0180","series-title":"An evaluation of nine rubella IgG assays highlights many discrepancies in the interpretation of the results","author":"Bouthry","year":"2014"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1401651X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1401651X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T03:33:14Z","timestamp":1598585594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1401651X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X1401651X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining rubella immunity in pregnant Alberta women 2009\u20132012","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}